MorphoSys AG – Product Pipeline Review – Q2 2011

Document Sample
MorphoSys AG – Product Pipeline Review – Q2 2011 Powered By Docstoc
					   MorphoSys AG – Product Pipeline Review – Q2 2011
                                                                                          Reference Code: GMDHC1312CDB

                                                                                               Publication Date: JULY 2011




MorphoSys AG – Product Pipeline Review – Q2 2011                                           GMDHC1312CDB / Published JULY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
MorphoSys AG – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                      2
List of Tables                                                                                                         4
List of Figures                                                                                                        5
MorphoSys AG Snapshot                                                                                                  6
    MorphoSys AG Overview                                                                                              6
    Key Information                                                                                                    6
    Key Facts                                                                                                          6
MorphoSys AG – Research and Development Overview                                                                       7
    Key Therapeutic Areas                                                                                              7
MorphoSys AG – Pipeline Review                                                                                         9
    Pipeline Products by Stage of Development                                                                          9
    Pipeline Products – Monotherapy                                                                                   10
MorphoSys AG – Pipeline Products Glance                                                                               11
    MorphoSys AG Clinical Stage Pipeline Products                                                                     11
         Phase II Products/Combination Treatment Modalities                                                           11
         Phase I Products/Combination Treatment Modalities                                                            12
    MorphoSys AG–Early Stage Pipeline Products                                                                        13
         Pre-Clinical Products/Combination Treatment Modalities                                                       13
         Discovery Products/Combination Treatment Modalities                                                          14
MorphoSys AG – Drug Profiles                                                                                          15
    MOR103                                                                                                            15
         Product Description                                                                                          15
         Mechanism of Action                                                                                          15
         R&D Progress                                                                                                 15
    MOR208                                                                                                            16
         Product Description                                                                                          16
         Mechanism of Action                                                                                          16
         R&D Progress                                                                                                 16
    MOR102                                                                                                            17
         Product Description                                                                                          17
         Mechanism of Action                                                                                          17
         R&D Progress                                                                                                 17
    MOR202                                                                                                            18
         Product Description                                                                                          18
         Mechanism of Action                                                                                          18
         R&D Progress                                                                                                 18
    MOR205                                                                                                            19
         Product Description                                                                                          19
         Mechanism of Action                                                                                          19
         R&D Progress                                                                                                 19
    MOR206                                                                                                            20
         Product Description                                                                                          20
         Mechanism of Action                                                                                          20
         R&D Progress                                                                                                 20
MorphoSys AG – Pipeline Analysis                                                                                      21
    MorphoSys AG – Pipeline Products by Therapeutic Class                                                             21




MorphoSys AG – Product Pipeline Review – Q2 2011                                          GMDHC1312CDB / Published JULY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                              Page(2)
MorphoSys AG – Product Pipeline Review



    MorphoSys AG - Pipeline Products By Target                                                                                   23
    MorphoSys AG – Pipeline Products by Route of Administration                                                                  24
    MorphoSys AG – Pipeline Products by Molecule Type                                                                            25
MorphoSys AG – Recent Pipeline Updates                                                                                           26
MorphoSys AG - Discontinued Pipeline Products                                                                                    27
    Discontinued Pipeline Product Profiles                                                                                       27
         MOR203                                                                                                                  27
         MOR101                                                                                                                  27
         MOR102                                                                                                                  27
MorphoSys AG – Locations And Subsidiaries                                                                                        28
    Head Office                                                                                                                  28
    Other Locations & Subsidiaries                                                                                               28
Financial Deals Landscape                                                                                                        29
    MorphoSys AG, Deals Volume Summary, 2004 to YTD 2011                                                                         29
    MorphoSys AG, Deals Summary By Region, 2004 to YTD 2011                                                                      30
    MorphoSys AG, Deals Summary, 2004 to YTD 2011                                                                                31
    MorphoSys AG Detailed Deal Summary                                                                                           32
         Acquisition                                                                                                             32
         MorphoSys Acquires AbD Serotec                                                                                          32
         Debt Offering                                                                                                           34
         MorphoSys Completes Private Placement Of $11 Million                                                                    34
         MorphoSys Expands Cooperation Agreement With Wacker Chemie                                                              35
         MorphoSys Enters Into Co-Development Agreement With DAIICHI SANKYO                                                      36
         AbD Serotec Enters Into Research Collaboration With Foundation for Innovative New Diagnostics                           37
         MorphoSys Enters Into Co-development Agreement With Galapagos                                                           38
         Sigma-Aldrich Enters Into An Agreement With MorphoSys                                                                   39
         Novartis Expands Collaboration Agreement With MorphoSys                                                                 40
         Genesis Research Enters Into Research Agreement With MorphoSys                                                          42
         MorphoSys Expands Co-Development Agreement With Pfizer                                                                  43
         Boehringer Ingelheim Expands Research Agreement With MorphoSys                                                          44
         MorphoSys Expands Collaboration With Centocor Ortho Biotech                                                             45
         Boehringer Ingelheim Enters Into An Agreement With MorphoSys                                                            46
         MorphoSys Enters Into Strategic Collaboration With Novartis                                                             47
         Licensing Agreements                                                                                                    48
         MorphoSys Enters Into Licensing Agreement With Shionogi                                                                 48
         Schering-Plough Extends Its Licensing Agreement With MorphoSys                                                          49
         Shionogi & Co. Extends Licensing Agreement With MorphoSys                                                               50
         Daiichi Sankyo Expands Licensing Agreement With MorphoSys                                                               51
         MorphoSys Extends Licensing Agreement With Crucell And DSM Biologics                                                    52
         Astellas Pharma Extends Collaboration With MorphoSys                                                                    53
         Dyax Enters Into Licensing Agreement With MorphoSys                                                                     54
         MorphoSys Enters Into Licensing Agreement With Astellas Pharma                                                          55
         MorphoSys Enters Into Licensing Agreement With Daiichi Sankyo                                                           56
         MorphoSys Enters Into Licensing Agreement With Merck                                                                    57
         MorphoSys Enters Into Licensing Agreement With Eli Lilly                                                                58
         MorphoSys Enters Into Licensing Agreement With Shionogi For HuCAL GOLD                                                  59
         ImmunoGen Enters Into Licensing Agreement With MorphoSys                                                                60
         MorphoSys Expands Licensing Agreement With Bristol-Myers Squibb                                                         61




MorphoSys AG – Product Pipeline Review – Q2 2011                                                     GMDHC1312CDB / Published JULY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                         Page(3)
MorphoSys AG – Product Pipeline Review



         Crucell And DSM Biologics Enter Into Licensing Agreement With MorphoSys                                      62
         MorphoSys Extends Licensing Agreement With Centocor                                                          63
         MorphoSys Enters Into Licensing Agreement With Centocor                                                      64
         GPC Biotech Extends License Agreement With MorphoSys                                                         65
         MorphoSys Enters Into Licensing Agreement With Bayer HealthCare                                              66
Appendix                                                                                                              67
    Methodology                                                                                                       67
         Coverage                                                                                                     67
         Secondary Research                                                                                           67
         Primary Research                                                                                             67
         Expert Panel Validation                                                                                      68
    Contact Us                                                                                                        68
    Disclaimer                                                                                                        68




Lis t o f Ta b le s
MorphoSys AG – Pipeline by Therapy Area and Indication, 2011                                                           8

MorphoSys AG – Pipeline by Stage of Development, 2011                                                                  9

MorphoSys AG – Monotherapy Products in Pipeline, 2011                                                                 10

MorphoSys AG - Phase II, 2011                                                                                         11

MorphoSys AG - Phase I, 2011                                                                                          12

MorphoSys AG - Pipeline By Therapeutic Class, 2011                                                                    22

MorphoSys AG - Pipeline By Target, 2011                                                                               23

MorphoSys AG – Pipeline By Route of Administration, 2011                                                              24

MorphoSys AG – Pipeline By Molecule Type, 2011                                                                        25

MorphoSys AG – Recent Pipeline Updates, 2011                                                                          26

MorphoSys AG - Discontinued Pipeline Products, 2010                                                                   27

MorphoSys AG, Subsidiaries                                                                                            28

MorphoSys AG, Deals Summary, 2004 to YTD 2011                                                                         29

MorphoSys AG, Deals Summary by Region, 2004 to YTD 2011                                                               30

MorphoSys AG, Deals Summary, 2004 to YTD 2011                                                                         31




MorphoSys AG – Product Pipeline Review – Q2 2011                
				
DOCUMENT INFO
Description: MorphoSys AG – Product Pipeline Review – Q2 2011 Summary Global Market Direct’s pharmaceuticals report, “MorphoSys AG - Product Pipeline Review - Q2 2011” provides data on the MorphoSys AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MorphoSys AG’s corporate website, SEC filings, investor presentations and featured press releases, both from MorphoSys AG and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - MorphoSys AG - Brief MorphoSys AG overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of MorphoSys AG human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of MorphoSys AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the MorphoSys AG’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate MorphoSys AG’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of MorphoSys AG in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the MorphoSys AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
BUY THIS DOCUMENT NOW PRICE: $500 100% MONEY BACK GUARANTEED
PARTNER GlobalMarketsDirect
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Global Markets Direct has a broad range of coverage over key market segments. It has a global scope, covering a broad range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries